AbbVie’s blockbuster eye drug Restasis under threat as FDA approves Viatris’ copycat esagonowsky Wed, 02/02/2022 – 15:56
Hepatitis E virus (HEV) can cause serious liver inflammation and is the most common cause of acute virus-mediated […]
When skin cancer is detected early, there is a good chance of recovery. Fraunhofer researchers have developed a […]
bmj;376/feb02_18/o275/FAF1faCredit: Tommy Leonardi, 2009Beatrice Mintz was driven by a curiosity about big questions. She wasn’t constrained by the […]
The word “backlog” has become synonymous with crowded hospital corridors, cancelled operations, and ambulances queuing around corners outside […]
Trust in the government and in the people around us correlates with lower covid-19 infection rates, a study […]
The NHS has “unacceptable levels of racism” that “cannot be ignored,” the BMA’s chair of council has said […]
The reported plan by health and social care secretary Sajid Javid to introduce “academy” style hospitals risks triggering […]
Novartis says Leqvio launch will feature a ‘modest initial ramp,’ but blockbuster potential awaits esagonowsky Wed, 02/02/2022 – […]
Novo touts diabetes, obesity growth, but Wegovy supply woes remain top of mind fkansteiner Wed, 02/02/2022 – 09:17